Ing. Filip Rázga, Ph.D.

2011

• Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients

  RÁČIL Zdeněk BUREŠOVÁ Lucie BREJCHA Martin PROCHÁZKOVÁ Jiřina ZOUNAR René TIMILSINA Shira RÁZGA Filip TOŠKOVÁ Martina CETKOVSKÝ Petr MAYER Jiří

  Article in Periodical

  American Journal of Hematology, year: 2011, volume: 86, edition: 9, DOI

• Cytogenetic abberation profile of chronic myeloid leukemia and its dynamic changes during imatinib therapy

  MILOSEVIC Jelena RÁZGA Filip DVOŘÁKOVÁ Dana JURČEK Tomáš BERG Tiina PUDA; Ana KLAMPFL Thorsten HARUTYUNYAN Ashot GISSLINGER Bettina GISSLINGER Heinz ORLANDI Ester BERNASCONI Paolo INDRÁK Karel DIVOKÁ Martina FABER Edgar MAYER Jiří RÁČIL Zdeněk KRÁLOVICS Róbert

  Conference abstract

  Year: 2011, type: Conference abstract

• Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?

  ŽÁČKOVÁ Daniela KLAMOVÁ Hana DUŠEK Ladislav MUŽÍK Jan MACHOVÁ POLÁKOVÁ Kateřina MORAVCOVÁ Jana JURČEK Tomáš DVOŘÁKOVÁ Dana RÁČIL Zdeněk POSPÍŠIL Zdeněk OLTOVÁ Alexandra MICHALOVÁ Kyra BŘEZINOVÁ Jana RÁZGA Filip DOUBEK Michael CETKOVSKÝ Petr TRNĚNÝ Marek MAYER Jiří

  Article in Periodical

  American Journal of Hematology, year: 2011, volume: 86, edition: 3, DOI

• Prediction of imatinib therapy response: a role of intracellular transporters hOCT-1 and ABCB1

  RÁZGA Filip RÁČIL Zdeněk BUREŠOVÁ L. MACHOVÁ POLÁKOVÁ Kateřina KLAMOVÁ Hana ŽÁČKOVÁ Daniela DVOŘÁKOVÁ Dana CETKOVSKÝ Petr MAYER Jiří

  Conference abstract

  Year: 2011, type: Conference abstract

• The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia

  RÁZGA Filip RÁČIL Zdeněk MACHOVÁ POLÁKOVÁ Kateřina BUREŠOVÁ Lucie KLAMOVA Hana ŽÁČKOVÁ Daniela DVOŘÁKOVÁ Dana POLÍVKOVÁ Václava CETKOVSKÝ Petr MAYER Jiří

  Article in Periodical

  International Journal of Hematology, year: 2011, volume: 94, edition: 3, DOI

• Účinnost a tolerance dasatinibu v léčbě pacientů s chronickou lymfocytární leukémií (CML) rezistentních/netolerujících imatinib léčených v podmínkách každodenní klinické praxe.

  ŽÁČKOVÁ Daniela KLAMOVÁ Hana MUŽÍK Jan CMUNT Eduard DOBEŠOVÁ Blanka RYŠAVÁ Jana RÁČIL Zdeněk MACHOVÁ POLÁKOVÁ Kateřina DVOŘÁKOVÁ Dana JURČEK Tomáš RÁZGA Filip MORAVCOVÁ Jana DOUBEK Michael BŘEZINOVÁ Jana OLTOVÁ Alexandra CETKOVSKÝ Petr TRNĚNÝ Marek DUŠEK Ladislav MAYER Jiří

  Conference abstract

  Year: 2011, type: Conference abstract

2010

• A case of a novel PML/RARA short fusion transcript with truncated transcription variant 2 of the RARA gene

  JEŽÍŠKOVÁ Ivana RÁZGA Filip GAZDOVÁ J. DOUBEK Michael JURČEK Tomáš KOŘÍSTEK Zdeněk MAYER Jiří DVOŘÁKOVÁ Dana

  Article in Periodical

  Molecular diagnosis and therapy, year: 2010, volume: 14, edition: 2

• Detection of an aberrant form of E13A2 BCR-ABL transcript causing failure of molecular diagnostics in patient with chronic myeloid leukemia (CML)

  JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana ŽÁČKOVÁ D. MAYER Jiří DVOŘÁKOVÁ Dana

  Conference abstract

  Year: 2010, type: Conference abstract

• Dynamics of the base of ribosomal A-site finger revealed by molecular dynamics simulations and Cryo-EM.

  RÉBLOVÁ Kamila RÁZGA Filip LI Wen GAO Haixiao FRANK Joachim ŠPONER Jiří

  Article in Periodical

  Nucleic Acids Research, year: 2010, volume: 38, edition: 4

• Failure of molecular diagnostics in chronic myeloid leukemia - an aberrant form of e13a2 BCR-ABL transcript causing false-negative results by standard PCR.

  JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela TOMÁŠIKOVÁ Lenka OLTOVÁ Alexandra MAYER Jiří

  Article in Periodical

  LEUKEMIA & LYMPHOMA, year: 2010, volume: 51, edition: 3